Congratulations to our president and CEO Eric Dube for being named an LGBTQ+ Leader in Biopharma by Endpoints News. In an interview with Endpoints, Eric reflects on the legacy of activists during the AIDS and HIV epidemic, and the impact of their work on patient advocacy and drug development today. He also talks about health equity, access to care, and the importance of listening to what patients need. Join us in celebrating Eric and all of this year's leaders for this impressive recognition. Access the full article at https://bit.ly/3VDCzyf #InRareForLife #TravereTherapeutics #PrideMonth #Pride #Pride2024
Congrats Eric!
Congrats Eric!
Clinical Account Manager -Rare Disease
2wWell deserved, Eric!